Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-21

FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., updating the generic product under ANDA 078627.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)